From the Analyst's Couch in 2008

Targeting apoptosis: selected anticancer strategies

Shane Storey
From the Analyst's Couch01 Dec 2008
Do molecularly targeted agents in oncology have reduced attrition rates?

Ian Walker
Herbie Newell
From the Analyst's Couch14 Nov 2008
A decade of the Fast Track programme

Janice M. Reichert
Stephanie L. Rochon
Bodi D. Zhang
From the Analyst's Couch24 Oct 2008
Hepatitis C therapies

Irena Melnikova
From the Analyst's Couch01 Oct 2008
Osteoporosis: overview and pipeline

Uma Yasothan
Santwana Kar
From the Analyst's Couch01 Sept 2008
Trends in disease focus of drug development

Johan P. E. Karlberg
From the Analyst's Couch01 Aug 2008
Novel agents in cystic fibrosis

Shane Storey
Graeme Wald
From the Analyst's Couch01 Jul 2008
Schizophrenia therapy: beyond atypical antipsychotics

Eric M. Snyder
Melanie R. Murphy
From the Analyst's Couch16 May 2008
Demographic factors in the Chinese health-care market

Susan Ward
From the Analyst's Couch01 May 2008
Therapies for COPD

Uma Yasothan
Santwana Kar
From the Analyst's Couch01 Apr 2008
Drug approvals and failures: implications for alliances

Elizabeth A. Czerepak
Stefan Ryser
From the Analyst's Couch01 Mar 2008
Therapeutic area crossroads: anti-angiogenesis

Ryan P. Million
From the Analyst's Couch01 Feb 2008
Trends in the globalization of clinical trials

Fabio A. Thiers
Anthony J. Sinskey
Ernst R. Berndt
From the Analyst's Couch01 Jan 2008

Quick links

Filter By: